CRISPR has opened new doors for treating genetic disorders.
CRISPR has opened new doors for treating genetic disorders. It’s being used in clinical trials for diseases like sickle cell disease, beta thalassemia, and Leber’s Congenital Amaurosis, a form of congenital blindness. These trials have shown promising results, with some patients experiencing significant improvements in their conditions. In cancer treatment, CRISPR is being explored to genetically engineer immune cells to fight tumors more effectively. This involves using CRISPR to modify T-cells, potentially making them more potent at targeting cancer​​. No doubt this biotech trend will keep improving the industry in 2024.